EndoRobotics Co., Ltd.

EndoRobotics develops and commercializes advanced robotic technologies for endoscopic surgery.

Founded 2019

Korea South 35 employees Series B Total: $13.90M Health Care, Robotics

EndoRobotics Co., Ltd., founded in 2019, is a pioneering company at the intersection of the Health Care and Robotics industries, headquartered in Korea South. The company focuses on developing and commercializing cutting-edge robotic technologies specifically designed for advanced therapeutic endoscopy, as encapsulated in their slogan: "Endoscope meets Robotics for Advanced Therapeutic Endoscopy."

With a recent injection of $8.30M from a Series B investment round on 14 August 2023, EndoRobotics is positioned to further enhance its capabilities. This round attracted a cohort of investors including L&S Venture Capital, Partners Investment, Mirae Asset Capital, Pathfinder H, and Donghoon Investment, signaling strong confidence in the company's potential.

EndoRobotics is advancing the landscape of surgical robotics, offering substantial value to an ever-evolving healthcare market and presenting lucrative opportunities for investors seeking innovation in medical technology.

Funding Stage	Amount	Investors	Lead Investors	Date
Series B	$8.30M	5	L&S Venture Capital, Partners Investment +3	14 Aug 2023
Grant	$300.00K	1	TIPS Program	01 Jun 2022
Series A	$3.70M	5	KNet Investment Partners, Pathfinder H +3	25 Aug 2021
Seed Round	$1.00M	1	Magna Investment	24 Jun 2020
Grant	$500.00K	1	TIPS Program	01 May 2019
Seed Round	$100.00K	1	Korea University Holdings	01 Apr 2019

Funding Stage

Amount

Investors

Lead Investors

Date

Series B

$8.30M

L&S Venture Capital, Partners Investment +3

14 Aug 2023

Grant

$300.00K

TIPS Program

01 Jun 2022

Series A

$3.70M

KNet Investment Partners, Pathfinder H +3

25 Aug 2021

Seed Round

$1.00M

Magna Investment

24 Jun 2020

Grant

$500.00K

TIPS Program

01 May 2019

Seed Round

$100.00K

Korea University Holdings

01 Apr 2019

FAQ About EndoRobotics Co., Ltd.

EndoRobotics develops and commercializes advanced robotic technologies for endoscopic surgery.

EndoRobotics Co., Ltd. was founded in 2019.

EndoRobotics Co., Ltd. is headquartered in Korea South.

EndoRobotics Co., Ltd. operates in Health Care and Robotics. Its work centres on Robotic Surgery, Endoscopic Technology, Medical Robotics and Advanced Therapeutic Endoscopy. Its customers include Healthcare Providers, Hospitals and Medical Centers and Gastroenterologists.

EndoRobotics Co., Ltd. has a B2B, D2C and B2D business model. Its revenue comes from Product Sales, Service Fee and Leasing/Rental.

EndoRobotics Co., Ltd. has approximately 35 employees.

EndoRobotics Co., Ltd. has completed 6 funding rounds, raising a total of $13.90M. The latest funding stage is Series B.

EndoRobotics Co., Ltd. offers: Endoscopic Submucosal Dissection (ESD), Endoscopic Sleeve Gastroplasty (ESG), Endoscopic Stitching, Endoscopic Mucosal Resection (EMR), Robotic Surgical Solutions.

Top alternatives and competitors to EndoRobotics Co., Ltd. include Virtual Incision, Beijing Remebot Technology Co., Ltd., NeoGuide Systems, Distalmotion, Bama Teknoloji. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.

EndoRobotics Co., Ltd. and Virtual Incision are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

General Information

Discover More

About EndoRobotics Co., Ltd.

Services & Products

Target Customers

Funding Rounds & Investors (6)

EndoRobotics Co., Ltd. Alternatives & Competitors

FAQ About EndoRobotics Co., Ltd.